Condition (MeSH)
Maxillary Diseases
ClinicalTrials.gov lists 37 trials for Maxillary Diseases or a narrower condition beneath it. Nobel Biocare has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
7 of the 37 trials are tagged with Maxillary Diseases itself; the rest are tagged with a narrower condition beneath it.
When did Maxillary Diseases trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 2/3
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 6 |
| 2024 | 5 |
| 2023 | 6 |
| 2022 | 2 |
| 2021 | 2 |
| 2020 | 3 |
| 2019 | 2 |
| 2018 | 2 |
| 2017 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 4.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 24 months across 15 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Maxillary Diseases trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Not applicable | 31 |
| Observational | 4 |
How many Maxillary Diseases trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 6 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
| Completed | 16 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Maxillary Diseases trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Nobel Biocare | 1 |
Which drugs are being tested for Maxillary Diseases? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Leukocyte Platelet Rich Fibrin | 2 |
| B | 1 |
| A- PRF | 1 |
Interventions as named in the registry (2)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Radiotherapy | 1 |
| Xenograft | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Maxillary Diseases? (54)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evaluation of photobiomodulation effects on pain, edema, paresthesia, and bone regeneration after surgically assisted rapid maxillary expansion: Study protocol for a randomized, controlled, and double blind clinical trial. | Medicine | 2019 | Yes |
| Repair of maxillary cystic bone defects with mesenchymal stem cells seeded on a cross-linked serum scaffold. | Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery | 2018 | Yes |
| Maxillary sinus floor pneumatization and alveolar ridge resorption after tooth loss: a cross-sectional study. | Brazilian oral research | 2018 | Yes |
| Orthodontic--surgical treatment and respiratory function: rhinomanometric assessment. | Minerva stomatologica | 2017 | Yes |
| Incidence of implant buccal plate fenestration in the esthetic zone: a cone beam computed tomography study. | The International journal of oral & maxillofacial implants | 2014 | Yes |
Showing 5 of 54 publications.
Sub-conditions in MeSH (2)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.